Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
ENTITY
SMARTSCORE: 3.2/5
Voronoi (310210 KS)
Watchlist
12
Analysis
Health Care
•
South Korea
Voronoi, Inc. operates as a drugs development company. The Company develops and manufactures kinase inhibitor and other new drugs. Voronoi provides services in Korea.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Celltrion Healthcare
•
23 Nov 2023 10:52
KOSDAQ150 Index Rebalance: 17 Changes a Side; Many Surprises
There are 17 changes a side for the KOSDAQ150 in Dec. Most of the inclusions were on expected lines, but there are many difference among the...
Brian Freitas
Follow
591 Views
Share
bullish
•
Celltrion Inc
•
01 Nov 2023 21:40
Celltrion Merger: Appraisal Rights & Passive Flows
The appraisal rights exercise period ends 13 Nov. Both companies are buying back shares. The last traded price is close to the appraisal price....
Brian Freitas
Follow
535 Views
Share
bearish
•
GMO Payment Gateway
•
28 Oct 2023 21:19
Index Rebalance & ETF Flow Recap: KS200, KQ150, Yuanta Div+, LIT, HSCI, IDX, Japan Positioning
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
Brian Freitas
Follow
794 Views
Share
bullish
•
Shinsung Delta Tech
•
23 Oct 2023 21:50
KOSDAQ150 Index Rebalance Preview: Big Sell Off Among Potential Inclusions as Momentum Fades
With momentum fading in Korea, the selloff has hit the potential adds to the KOSDAQ150 especially hard. There could be a few constituent changes...
Brian Freitas
Follow
617 Views
Share
bullish
•
Lasertec Corp
•
09 Sep 2023 22:30
Index Rebalance & ETF Flow Recap: NKY, ASX, CSI300, KOSDAQ150, Yuanta ETFs, MVA, MVW, SMH
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
Brian Freitas
Follow
616 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.2
x